Stellate cells and the ″reversible component″ of portal hypertension

Digestive and Liver Disease

Volumn 32, Issue 2, 2000, Pages 104-107

  de Franchis, R ^a  

^a Cattedra di Gastroenterologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENOMEDULLIN; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BOSENTAN; CATECHOLAMINE; CYTOKINE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR ANTAGONIST; GROWTH FACTOR; HORMONE; ISOSORBIDE 5 NITRATE; LOSARTAN; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E1; SUBSTANCE P; THROMBIN; VASOPRESSIN;

ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; ITO CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER PERFUSION; NERVE CELL; NONHUMAN; PERFUSION PRESSURE; PHENOTYPE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROTEIN SYNTHESIS; RAT; SHEAR STRESS; STELLATE CELL; VASCULAR RESISTANCE; VASOCONSTRICTION; BLOOD FLOW VELOCITY; LIVER; LIVER CIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

BLOOD FLOW VELOCITY; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRCULATION; PORTAL PRESSURE; VASCULAR RESISTANCE;

EID: 0033624347     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(00)80394-1     Document Type: Article

References (36)

1. L.M. Blendis H. Orrego I.R. Crossley J.E. Blake A. Medline Y. Israel The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease Hepatology 2 1982 539 546
2. T.B. Reynolds H.A. Edmonson Alcoholic hepatitis Ann Intern Med 74 1971 441 442
3. S. Beker J. Valencia-Paparcen Portal hypertension syndrome: a comparative analysis of bilharzial fibrosis and hepatic cirrhosis Am J Dig Dis 13 1968 1047 1054
4. P.S. Bhathal H.G. Grossman Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators J Hepatol 1 1985 325 337
5. J.X. Zhang W. Pegoli Jr M.G. Clemens Endothelin-1 induces direct constriction of hepatic sinusoids Am J Physiol 266 1994 G624 G632
6. J.X. Zhang M. Bauer M.G. Clemens Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver Am J Physiol 269 1995 G69 G77
7. M. Pinzani P. Failli C. Ruocco A. Casini S. Milani E. Baldi Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium tranients J Clin Invest 90 1992 642 646
8. M. Pinzani P. Gentilini Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis Semin Liver Dis 19 1999 397 410
9. A. Lang D.A. Brenner Gene regulation in hepatic stellate cells Ital J Gastroenterol Hepatol 31 1999 173 179
10. M. Pinzani Novel insight into the pathology and physiology of the Ito cell Pharmac Ther 66 1995 387 412
11. D.C. Rockey C.N. Housset S.L. Friedman Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo J Clin Invest 92 1993 1795 1804
12. N. Kawada T.-A. Tran-Thi H. Klein K. Decker Eicoesanoid-mediated contractility of hepatic stellate cells Biochem J 285 1992 367 371
13. N. Kawada T.A. Tran-Thi H. Klein K. Decker The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin-1 and nitric oxide in the regulation of the sinusoidal toms Eur J Biochem 213 1993 815 823
14. M. Yanagisawa H. Kurihara S. Kimura Y. Tomobe M. Kobayashi Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
15. M. Pinzani S. Milani R. De Franco C. Grappone A. Caligiuri A. Gentilini Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells Gastroenterology 110 1996 534 548
16. S. Moller V. Gulberg J.H. Henriksen A.L. Gerbes Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic hemodynamics J Hepatol 23 1995 135 144
17. A.L. Gerbes S. Moller V. Gülberg J.H. Henriksen Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function Hepatology 21 1995 735 739
18. A. Leivas W. Jimenez J. Bruix L. Boix J. Bosch V. Arroyo Gene expression of endothelin-1 and ETA and ETB receptors in human cirrhosis: relationship with hepatic hemodynamics J Vase Res 35 1998 186 193
19. D.C. Rockey R.A. Weisiger Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance Hepatology 24 1996 233 240
20. J. Reichen A.L. Gerbes M.J. Steiner H. Sagesser M. Clozel The effect of endothelin and its antagonist bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver J Hepatol 28 1998 1020 1030
21. P. Sogni R. Moreau A. Gomola A. Gadano S. Cailmail Y. Calmus Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist in portal hypertensive rats Hepatology 28 1998 655 659
22. J.L. Poo W. Jimenez R. Maria Muñoz M. Bosch-Marce N. Bordas M. Morales-Ruiz Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects Gastroenterology 116 1999 161 167
23. S. Moncada A. Higgs The L-arginine-nitric oxide pathway N Engl J Med 329 1992 2002 2012
24. W.C. Sessa The nitric oxide synthase family of proteins J Vase Res 32 1994 131 143
25. R. Wiest R.J. Groszmann Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance Semin Liver Dis 19 1999 411 426
26. V. Shah F.G. Haddad G. Garcia-Caddena J.A. Frangos A. Mennone R.J. Groszmann Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids J Clin Invest 100 1997 2923 2930
27. V. Shah M. Toruner F. Haddad G. Cadelina A. Papapetropoulos K. Choo Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat Gastroenterology 117 1999 1222 1228
28. M.K. Mittal T.K. Gupta F.Y. Lee C.C. Sieber R.J. Groszmann Nitric oxide modulates hepatic vascular tone in normal liver Am J Physiol 267 1994 G416 G422
29. D.C. Rockey J.J. Chung Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension Gastroenterology 114 1998 344 351
30. T.K. Gupta M. Toruner M.K. Chung R.J. Groszmann Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats Hepatology 28 1998 926 931
31. N. Kawada T. Kuroki M. Uoya M. Inoue K. Kobayashi Smooth muscle a-actin expression in rat hepatic stellate cells is regulated by nitric oxide and cAMP Biochem Biophys Res Commun 229 1996 238 242
32. A.W. Schneider J.F. Kalk C.P. Klein Effect of Losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis Hepatology 29 1999 334 339
33. G. Garcia-Tsao Angiotensin II receptor antagonists in the pharmacological therapy of portal hypertension: a caution Gastroenterology 117 1999 740 742
34. F. Salerno G. Borroni E. Lorenzano D. Solenghi M. Cazzaniga F. Bissoli Long-term administration of Isosorbide-5-mononitrate does not impair renal function in cirrhotic patients Hepatology 23 1996 1135 1140
35. M. Angelico L. Carli C. Piat S. Gentile L. Capocaccia Effects of Isosorbide-5-Mononitrate compared to propranolol on first bleeding and long-term survival in cirrhosis Gastroenterology 113 1997 1632 1639
36. D. Rockey The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide Hepatology 25 1997 2 5